The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

North Carolina state leaders announced a major deal to invest $700 million in a manufacturing plant in Wake County, bringing ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.